- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00991549
Diabetes Prevention In Estrie
Comparative Evaluation of the Effectiveness of 2 Available Resources in Estrie, for the Prevention of Type 2 Diabetes in High-risk Subjects
This study compared the efficacy at one year of an interdisciplinary approach including individual counseling and group seminars versus group seminars alone to induce weight loss in subjects at high risk of developing type 2 diabetes.
This study also compare if a participant's presence in small informative meeting groups as the only form of intervention is sufficient to induce a lifestyle change, thus inducing the weight loss needed for the prevention of the diseases associated with obesity.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Eligible participants will be randomized into 2 intervention groups (30 per group):
- Small Meeting groups: a curriculum of 25 meeting-seminars will take place for 45 minutes, each one approaching various aspects of nutrition, physical activity, psychology, motivation and medical needs. These seminars are administered by the professionals of the obesity clinic and are already in place. However, these are usually only offered to the patients registered with the obesity clinic.
- Obesity Clinic of CHUS: combination of 25 described meeting-seminars see-high, in addition to individual interviews every 6 weeks with the interdisciplinary team of the obesity clinic of CHUS (usual operation).
Subjects will be evaluated initially and then every 3 months during 1 year by the following measurements: questionnaires to evaluate motivation and physical activity; 3 day dietary journals; weight assessment, using both metabolic and mechanical balance; waist circumference; and blood pressure.
A medical evaluation with size measure, a test evaluating knowledge of the participants on obesity, OGTT (Oral Glucose Tolerance Test) - a 5 hour determination of secretion and resistance to insulin, insulin-mediated suppression of plasma non-esterified fatty acids, a plasma lipid profile, accelerometry, bio electric impedance, and an activity physical test (6 minute walk test) will be carried out initially, and then repeated for up to 1 year.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Sherbrooke, Quebec, Canada
- Centre de Recherche Clinique (CRC), Centre Hospitalier Universitaire de Sherbrooke
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- pre diabetic state underlined by a marginal fasting glycemia between 6,1 and 6,9 mmol/L and/or a glucose intolerance with glucose confirmed by an OGTT 2 hours
- overweight or obesity (BMI > 27 kg/m² ; (Body Mass Index))
- enlightened assent
Exclusion Criteria:
- Impossibility to be present at the visits
- Physical/motor incapacity (or other) making one unable and/or insecure to walk at a moderate to rapid speed of 6 min and more
- Use of an anti-obesity treatment during the last 3 months
- Bariatric Surgery in the past
- Planned Pregnancy
- Pacemaker
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
interdisciplinary weight loss intervention
|
one-year individualized interdisciplinary weight loss program vs. small group seminars on healthy lifestyle
|
Active Comparator: 2
Small group seminars without interdisciplinary intervention
|
one-year individualized interdisciplinary weight loss program vs. small group seminars on healthy lifestyle
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
a weight loss of 7% in at least 19% of the subjects
Time Frame: one year
|
one year
|
reduced body weight of at least 5.6 kg in at least 25% of the subjects
Time Frame: one year
|
one year
|
an increase in the level of physical activity by at least 150 minutes per week in at least 29% of the subjects
Time Frame: one year
|
one year
|
a reduced daily caloric intake of at least 450 kcal/jour in at least 25% of the subjects
Time Frame: one year
|
one year
|
a reduced percentage of the calories introduced in the form of fat of at least 6.6%, in absolute value, in at least 25% of the subjects
Time Frame: one year
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
change in insulin sensitivity by HOMA
Time Frame: one year
|
one year
|
change in insulin secretion during an OGTT by deconvolution of plasma c-peptide
Time Frame: one year
|
one year
|
change in beta cell function by calculation of the disposition index
Time Frame: one year
|
one year
|
change in insulin-mediated suppression of plasma non-esterified fatty acids during an OGTT
Time Frame: one year
|
one year
|
relation between weight loss and change in insulin sensitivity, beta cell function, and insulin-mediated suppression of plasma non-esterified fatty acids
Time Frame: one year
|
one year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Marie-France Langlois, MD, Medecine Department, Division of endocrinology, CHUS
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 04-087
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsNot yet recruitingOverweight and Obesity | Overweight, Childhood | Overweight, Infant
-
Children's Hospital Los AngelesUniversity of Southern California; Tufts Medical CenterRecruitingOverweight and Obesity | Overweight AdolescentsUnited States
-
University of AarhusThe Danish Dairy Research Foundation, Denmark; Sygekassernes HelsefondCompletedOverweight and Obesity | Overweight Adolescents | Metabolic DiseaseDenmark
-
Memorial Sloan Kettering Cancer CenterRecruitingObesity | Overweight | Overweight and Obesity | Obese | Overweight or ObesityUnited States
-
University Hospital Bispebjerg and FrederiksbergUniversity of CopenhagenCompleted
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Khyber Medical University PeshawarRecruitingObesity, OverweightPakistan
-
National Taiwan University HospitalCompleted
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Children's Hospital SrebrnjakBelupo; Podravka d.d.RecruitingBody Weight | Overweight and ObesityCroatia
Clinical Trials on interdisciplinary intervention or meeting-seminars
-
Marie-France HivertCanadian Diabetes Association; Danone InstituteCompleted
-
Université de SherbrookeCompletedObesity | Metabolic SyndromeCanada
-
Vastra Gotaland RegionRecruitingChronic Pain | Pain ManagementSweden
-
Umeå UniversityRegion VästerbottenNot yet recruiting
-
Chang Gung Memorial HospitalNational Health Research Institutes, TaiwanCompleted
-
Oslo University HospitalUniversity of Oslo; Norwegian University of Science and Technology; University... and other collaboratorsActive, not recruiting
-
Sykehuset Innlandet HFUniversity of BergenCompletedMusculoskeletal DiseasesNorway
-
Ana R. DamasoRaquel Munhoz da Silveira Campos; Sofia Emanuelle Castro; Ana Claudia Pelissari...Unknown
-
Federal University of São PauloUnknown
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHealth Care ProviderBrazil, Colombia, Peru